Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Chitsaz

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|March 31, 2011
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary studyMasoud Etemadifar, Mojtaba Kazemi, Ahmad Chitsaz, et al.
Parkinson'S Disease|November 19, 2014
Validation of the persian translation of the swallowing disturbance questionnaire in Parkinson's disease patientsAli Rajaei, S Abolfazl Azargoon, Mohammad Hussein Nilforoush, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|August 21, 2013
Association between serum biochemical levels, related to bone metabolism and Parkinson's diseaseRokhsareh Meamar, Mohammad Maracy, Ahmad Chitsaz, et al.
Frontiers in Immunology|March 10, 2023
Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicityNahad Sedaghat, Masoud Etemadifar, Noushin Lotfi, et al.
Current Alzheimer Research|April 29, 2025
The Footprint of CHASERR as a Potential Culprit in Alzheimer's Disease Patients: An In-Silico-Experimental StudyZahra Khosroabadi, Anoosha Niazmand, Seyed Reza Mousavi, et al.
International Journal of Endocrinology|August 20, 2013
25-hydroxyvitamin d and severity of Parkinson's diseaseAhmad Chitsaz, Mohammad Maracy, Keivan Basiri, et al.
Advanced Biomedical Research|August 12, 2015
The association between saliva control, silent saliva penetration, aspiration, and videofluoroscopic findings in Parkinson's disease patientsAli Rajaei, Fereshteh Ashtari, Seyed Abolfazl Azargoon, et al.
Iranian Journal of Neurology|September 7, 2018
Demographic features and clinical characteristics of patients with Parkinson's disease in Isfahan, IranMehri Salari, Omid Mirmosayyeb, Masoud Etemadifar, et al.
Iranian Journal of Neurology|November 9, 2017
Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson's disease, Isfahan, IranMehri Salari, Ahmad Chitsaz, Masoud Etemadifar, et al.
Multiple Sclerosis and Related Disorders|May 31, 2020
The effect of fampridine on the risk of seizure in patients with multiple sclerosisMasoud Etemadifar, Masih Saboori, Ahmad Chitsaz, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|March 31, 2011
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary studyMasoud Etemadifar, Mojtaba Kazemi, Ahmad Chitsaz, et al.
Parkinson'S Disease|November 19, 2014
Validation of the persian translation of the swallowing disturbance questionnaire in Parkinson's disease patientsAli Rajaei, S Abolfazl Azargoon, Mohammad Hussein Nilforoush, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|August 21, 2013
Association between serum biochemical levels, related to bone metabolism and Parkinson's diseaseRokhsareh Meamar, Mohammad Maracy, Ahmad Chitsaz, et al.
Frontiers in Immunology|March 10, 2023
Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicityNahad Sedaghat, Masoud Etemadifar, Noushin Lotfi, et al.
Current Alzheimer Research|April 29, 2025
The Footprint of CHASERR as a Potential Culprit in Alzheimer's Disease Patients: An In-Silico-Experimental StudyZahra Khosroabadi, Anoosha Niazmand, Seyed Reza Mousavi, et al.
International Journal of Endocrinology|August 20, 2013
25-hydroxyvitamin d and severity of Parkinson's diseaseAhmad Chitsaz, Mohammad Maracy, Keivan Basiri, et al.
Advanced Biomedical Research|August 12, 2015
The association between saliva control, silent saliva penetration, aspiration, and videofluoroscopic findings in Parkinson's disease patientsAli Rajaei, Fereshteh Ashtari, Seyed Abolfazl Azargoon, et al.
Iranian Journal of Neurology|September 7, 2018
Demographic features and clinical characteristics of patients with Parkinson's disease in Isfahan, IranMehri Salari, Omid Mirmosayyeb, Masoud Etemadifar, et al.
Iranian Journal of Neurology|November 9, 2017
Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson's disease, Isfahan, IranMehri Salari, Ahmad Chitsaz, Masoud Etemadifar, et al.
Multiple Sclerosis and Related Disorders|May 31, 2020
The effect of fampridine on the risk of seizure in patients with multiple sclerosisMasoud Etemadifar, Masih Saboori, Ahmad Chitsaz, et al.
Pageof 7